Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer.

Peter L LeeKaren RuthDouglas Y LeeMark A HallmanDavid Y T ChenJessica Karen WongAndres F CorreaIavor VeltchevTeh LinXiaoming ChenJoseph PanettaAlexander KutikovEric M Horwitz

Published in: Brachytherapy (2024)

Overall toxicity rates support the safety of prostate brachytherapy. HDR monotherapy is associated with significantly less perioperative and subacute postoperative GU events when compared to LDR monotherapy. Cardiopulmonary events were equally rare in both groups.

Keyphrases

prostate cancer
combination therapy
patients undergoing
high dose
open label
radiation therapy
cardiac surgery
radical prostatectomy
locally advanced
oxidative stress
acute kidney injury